Mark Lewis: Fascinating work by Surekha Yadav et al. on midstream PRRT evaluation

Mark Lewis, Director of GI Oncology, shared on X/Twitter:

“Fascinating work from UCSF Imaging neuroendocrine group on midstream PRRT evaluation and its effect on real-time management.

Echoes of NETTER-2 for me insofar as higher grade increased rate of change.”

Source: Mark Lewis/X

Mark A. Lewis is the Director of Gastrointestinal Oncology at Intermountain Healthcare in Utah, the Co-Chair of adolescent & young adult (AYA) oncology in the SWOG cooperative group, and the Vice President of American Multiple Endocrine Neoplasia Support. Dr. Lewis is also a well-known patient advocate and social media influencer.